Israël - Hebreeuws - Ministry of Health

dexcel ltd, israel - betamethasone as dipropionate; calcipotriol as hydrate - משחה - betamethasone as dipropionate 0.5 mg/g; calcipotriol as hydrate 50 mcg/g - calcipotriol, combinations - calcipotriol, combinations - topical treatment of stable plaque psoriasis vulgaris amenable to topical therapy.

Israël - Hebreeuws - Ministry of Health

dexcel ltd - betamethasone as dipropionate 0.5 mg / 1 g; calcipotriol as hydrate 50 mcg / 1 g - gel - betamethasone - topical treatment of psoriasis vulgaris on the scalp and topical treatment of mild to moderate “non-scalp” plaque psoriasis vulgaris in adults 18 years of age and older.

Israël - Hebreeuws - Ministry of Health

dexcel ltd, israel - sodium fusidate - טבליה - sodium fusidate 250 mg - fusidic acid - fusidic acid - for the treatment of infections caused by staphylococcus.

Israël - Hebreeuws - Ministry of Health

dexcel ltd, israel - tacrolimus - משחה - tacrolimus 0.03 %w/w - tacrolimus - tacrolimus - treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies.maintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i.e. occurring 4 or more times per year) who have had an initial response to a maximum of 6 weeks treatment of twice daily tacrolimus ointment (lesions cleared, almost cleared or mildly affected).

Israël - Hebreeuws - Ministry of Health

dexcel ltd, israel - tacrolimus - משחה - tacrolimus 0.1 %w/w - tacrolimus - tacrolimus - treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies.maintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i.e. occurring 4 or more times per year) who have had an initial response to a maximum of 6 weeks treatment of twice daily tacrolimus ointment (lesions cleared, almost cleared or mildly affected).

Israël - Hebreeuws - Ministry of Health

dexcel ltd, israel - betamethasone as dipropionate; calcipotriol as monohydrate - קצף לעור - betamethasone as dipropionate 0.5 mg / 1 g; calcipotriol as monohydrate 50 mcg / 1 g - calcipotriol, combinations

Israël - Hebreeuws - Ministry of Health

dexcel ltd, israel - betamethasone as dipropionate; calcipotriol as monohydrate - קצף לעור - betamethasone as dipropionate 0.5 mg / 1 g; calcipotriol as monohydrate 50 mcg / 1 g - calcipotriol, combinations

Israël - Hebreeuws - Ministry of Health

leopharm ltd. לאופארם בע"מ - רופא - ציוד רפואי לרפואת עיניים לניתוחי עיניים ולאבחנת מחלות עיניים

Israël - Hebreeuws - Ministry of Health

j-c health care ltd - etravirine - טבליה - etravirine 100 mg - etravirine - etravirine - intelence is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in antiretroviral treatment-experienced adult patients including those with non-nucleoside reverse transcriptase inhibitor (nnrti) resistance. treatment history and when available resistance testing should guide the use of intelence. in patients who have experienced virological failure on an nnrti- and nucleoside or nucleotide reverse transcriptase inhibitor (n[t]rti) - containing regimen intelence is not recommended for use in combination with n(t)rtis only.

Israël - Hebreeuws - Ministry of Health

j-c health care ltd - etravirine - טבליה - etravirine 200 mg - etravirine - etravirine - intelence is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in antiretroviral treatment-experienced adult patients including those with non-nucleoside reverse transcriptase inhibitor (nnrti) resistance. treatment history and when available resistance testing should guide the use of intelence. in patients who have experienced virological failure on an nnrti- and nucleoside or nucleotide reverse transcriptase inhibitor (n[t]rti)- containing regimen intelence is not recommended for use in combination with n(t)rtis only.